| 12390464 |
Treatment of EGFR mutant-related cancers using a combination of EGFR and CDK4/6 inhibitors |
Michael N. Greco, Michael John Costanzo, Michael Alan Green, Jirong Peng |
2025-08-19 |
| 12258365 |
Organophosphorus-substituted compounds as c-MET inhibitors and therapeutic uses thereof |
Jirong Peng, Michael N. Greco, Michael John Costanzo, Michael Alan Green |
2025-03-25 |
| 12187707 |
Pharmaceutical formulations of N-(2-(2-(dimethylamino)ethoxy)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylaminde and salts thereof |
Michael N. Greco, Michael John Costanzo, Michael Alan Green, Jirong Peng, Victoria Lynn Wilde |
2025-01-07 |
| 11414401 |
Substituted 2-anilinopyrimidine derivatives as EGFR modulators |
Jirong Peng, Michael John Costanzo, Michael N. Greco, Michael Alan Green, Victoria Lynn Wilde |
2022-08-16 |
| 11352341 |
2H-indazole derivatives as CDK4 and CDK6 inhibitors and therapeutic uses thereof |
Michael N. Greco, Michael John Costanzo, Jirong Peng |
2022-06-07 |
| 11180478 |
Pharmaceutical formulations of N-(2-(2-(dimethylamino) ethoxy)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide and salts thereof |
Michael N. Greco, Michael John Costanzo, Michael Alan Green, Jirong Peng, Victoria Lynn Wilde |
2021-11-23 |
| 11052086 |
2-anilinopyrimidine derivatives as therapeutic agents for treatment of brain cancers |
Michael N. Greco, Michael John Costanzo, Michael Alan Green, Jirong Peng, Victoria Lynn Wilde |
2021-07-06 |
| 10844045 |
Pharmaceutical salts N-(2-(2-(dimethylamino)ethoxy)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide and crystalline forms thereof |
Michael N. Greco, Michael John Costanzo, Michael Alan Green, Jirong Peng, Victoria Lynn Wilde |
2020-11-24 |
| 10590111 |
Substituted 2-anilinopyrimidine derivatives as EGFR modulators |
Jirong Peng, Michael John Costanzo, Michael N. Greco, Michael Alan Green, Victoria Lynn Wilde |
2020-03-17 |
| 10239864 |
2-H-indazole derivatives as cyclin-dependent kinase (CDK) inhibitors and therapeutic uses thereof |
Michael N. Greco, Michael John Costanzo, Jirong Peng, Victoria Lynn Wilde |
2019-03-26 |
| 9878994 |
2-H-indazole derivatives as cyclin-dependent kinase (CDK) inhibitors and therapeutic uses thereof |
Michael N. Greco, Michael John Costanzo, Jirong Peng, Victoria Lynn Wilde |
2018-01-30 |
| 9820721 |
Aspiration and biopsy needle apparatus and devices and applications thereof |
Jirong Peng |
2017-11-21 |
| 9359370 |
Icotinib hydrochloride, synthesis, crystalline forms, pharmaceutical compositions, and uses thereof |
Yinxiang Wang, Guojian Xie, Lieming DING, Fenlai Tan, Yunyan Hu +6 more |
2016-06-07 |
| 9163010 |
Indolinone protein kinase inhibitors |
Guojian Xie |
2015-10-20 |
| 8822482 |
Icotinib hydrochloride, synthesis, crystalline forms, pharmaceutical compositions, and uses thereof |
Yinxiang Wang, Guojian Xie, Lieming DING, Fenlai Tan, Yunyan Hu +6 more |
2014-09-02 |
| 7078409 |
Fused quinazoline derivatives useful as tyrosine kinase inhibitors |
Guojian Xie, Charles Davis, Zhengzhuang Cheng, Hang Chen, Yinxiang Wang +1 more |
2006-07-18 |